scholarly journals KŪRYBINIŲ VEIKLŲ POVEIKIS PACIENTŲ DĖMESIO KONCENTRACIJOS KAITAI PO GALVOS SMEGENŲ INSULTO

2021 ◽  
Vol 31 (2) ◽  
pp. 116-119
Author(s):  
Jomantė Buzytė ◽  
Rūta Jonaitienė

Tyrimo tikslas – išsiaiškinti kūrybinės veiklos poveikį pacientų dėmesio koncentracijai po galvos smegenų insulto. Tyrimo metodai. Tyrimas atliktas Vilniaus universiteto ligoninės Santaros klinikų Reabilitacijos, fizinės ir sporto medicinos centro I stacionarinės reabilitacijos skyriuje. Tyrimo laikotarpis 2017 m. spalis – 2018 m. kovas. Tyrime dalyvavo 30 pacientų, po galvos smegenų insulto atvykusių į stacionarinę reabilitaciją ir turinčių dėmesio koncentracijos problemų. Tiriamieji, atitikę įtraukimo į tyrimą kriterijus, atsitiktinės atrankos būdu suskirstyti į dvi grupes: tiriamąją ir kontrolinę po 15 asmenų. Tyrimui taikytas anketinis testavimas: sociodemografinių duomenų anketa, Trumpas protinės būklės vertinimo testas (Mini Mental), Monrealio kognityvinis testas (MOCA) bei Skaičių pakeitimo simboliais testas (Digit-Symbol substitution test, DSST), kurie padėjo įvertinti tiriamųjų dėmesio sutelktumą, apimtį ir perkėlimą. Taikyti įprastinės ergoterapijos užsiėmimai, kūrybinės veiklos ir gautų duomenų statistinė analizė. Rezultatai: kūrybinės veiklos terapija daro teigiamą įtaką pacientų po galvos smegenų insulto dėmesio sutelktumui. Visiems tiriamosios grupės pacientams dėmesio sutelktumas pagerėjo 30 procentų. Apskaičiavus taikyto poveikio reikšmingumą, skirtumas tarp I ir II tyrimo rezultatų laikomas statistiškai patikimu (p<0,05). Dėmesio apimties sutrikimų po taikytos kūrybinės veiklos neturėjo 67 proc. pacientų. Apskaičiavus taikyto poveikio reikšmingumą, skirtumas tarp I ir II tyrimo laikomas statistiškai nepatikimu (p>0,05). Pacientų, kuriems buvo taikoma kūrybinės veiklos terapija, dėmesio perkėlimas pagerėjo vidutiniškai 3,6 balo. Apskaičiavus taikyto poveikio reikšmingumą, skirtumas tarp I ir II tyrimo rezultatų laikomas statistiškai patikimu (p<0,05).

2021 ◽  
Vol 11 (7) ◽  
pp. 881
Author(s):  
Marianna Tsatali ◽  
Eleni Poptsi ◽  
Despina Moraitou ◽  
Christina Agogiatou ◽  
Evaggelia Bakoglidou ◽  
...  

Objective: The aim of the current study was to estimate the discriminant potential and validity of the Digit Symbol Substitution Test (DSST) of the WAIS-R in the Greek elderly population meeting criteria for subjective cognitive decline (SCD), mild cognitive impairment (aMCI; amnestic subtype), or Alzheimer’s disease dementia (ADD). Method: Four hundred eighty-eight community-dwelling older adults, visitors of the Day Center of Alzheimer Hellas, participated in the study. Two hundred forty-three of them met the criteria for ADD, one hundred eighty-two for aMCI and sixty-three for SCD. Results: Path analysis indicated that the DSST score is affected by age group, educational level, and diagnostic category, but is not affected by gender. The ROC curve analysis showed that the DSST sum score could perfectly differentiate SCD from ADD patients, whereas test’s discriminant potential between aMCI and dementia ADD’s subtype was satisfactory. However, DSST was unable to separate the SCD from the aMCI group. Conclusion: It appears that the DSST is unable to separate the SCD from aMCI population. Therefore, the test in question may be insensitive to incipient cognitive decline. On the contrary, the discriminant potential of the DSST as regards SCD and ADD is excellent, while discrimination between aMCI and ADD is good.


1982 ◽  
Vol 14 (5) ◽  
pp. 463-466 ◽  
Author(s):  
Daniel R. McLeod ◽  
Roland R. Griffiths ◽  
George E. Bigelow ◽  
John Yingling

2006 ◽  
Vol 103 (1) ◽  
pp. 121-130 ◽  
Author(s):  
Semion Kertzman ◽  
Zeev Ben-Nahum ◽  
Iosef Gotzlav ◽  
Haim Grinspan ◽  
Moshe Birger ◽  
...  

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 76-76
Author(s):  
Aaron Smith ◽  
Matthew Taylor ◽  
Jim Backes ◽  
Juleah Littrell ◽  
Caitlin Boeckman ◽  
...  

Abstract Objectives Peripheral insulin resistance (IR) and impaired glucose metabolism increases the risk for cognitive decline. However, data looking at peripheral IR's relationship with cognition in cognitively normal adults is limited. This study aimed to assess the relationship between peripheral IR and tests of speed of processing (SOP) in cognitively normal older adults using a novel IR measure. Methods Baseline data from 56 cognitively normal older adults participating in a nutrition intervention study (Nutrition Interventions for Cognitive Enhancement study; NICE study) were analyzed. Fasting blood draws were attained, and peripheral IR was measured using Quest Diagnostics’ Cardio IQ Insulin Resistance Panel (Test Code: 36,509). A cognitive battery was conducted by a trained psychometrician. Z-Scores of the Digit Symbol Substitution Test, Stroop Color, Stroop Word, Stroop Interference, and Stroop Letter Number Sequencing and Crossing-Off tests were combined to give a global SOP score. We constructed ordinary least squares regression models to assess IR's relationships with individual SOP tests and global SOP, including age and education as covariates. Statistical analyses were performed using R (v. 3.6.2; R Foundation, Vienna, Austria). Statistical significance was set at P &lt; 0.05. Results Participants were 77% female and had a mean age of 72.1 ± 4.9 years. Higher IR scores were related to poorer performance on the Digit Symbol Substitution Test (β = −0.26, P = 0.04). IR scores were not related to other individual cognitive tests: Stroop Color (β = −0.17, P = 0.20), Stroop Word (β = −0.19, P = 0.11), Stroop Interference (β = −0.14, P = 0.28), Stroop Letter Number Sequencing (β = 0.03, P = 0.83), Crossing-Off (β = −0.18, P = 0.15), or Global SOP (β = −0.20, P = 0.11). Conclusions There was a relationship between higher IR scores and poorer performance on the Digit Symbol Substitution Test. Although other SOP tests were not significantly correlated with IR scores, directionality of the relationships indicated trend for higher IR being related to lower SOP. Consequently, maintaining insulin sensitivity with healthy lifestyle choices may be important for healthy aging. Future analyses with a larger sample size will be more informative for understanding the relationship between IR and SOP. Funding Sources National Institute on Aging.


Author(s):  
Brianne Magouirk Bettcher ◽  
David J. Libon ◽  
Edith Kaplan ◽  
Rod Swenson ◽  
Dana L. Penney

2018 ◽  
Vol 4 (1) ◽  
pp. 41 ◽  
Author(s):  
Ankush Singhal, MBBS, MD, MRCPsych ◽  
B.M. Tripathi, MBBS, MD, MRCPsych ◽  
Hem Raj Pal, MBBS, MD ◽  
Renuka Jena, PhD ◽  
Raka Jain, MSc, PhD, Cchem, FRSC

Objective: Patients on buprenorphine maintenance for opioid dependence often abuse its additional doses over and above the maintenance dose. Being a psychoactive agent, it may affect psychomotor performance with all its consequences, for example, effect on quality of life. This study was conducted to assess the effects of its additional doses on psychomotor performance in patients who are maintained on it.Design and Setting: This was an interventional study, carried out in an in-patient setting in a tertiary care national drug dependence treatment center.Participants: It included 19 subjects maintained on buprenorphine, 4 mg/d (s/L) for at least a month.Intervention: Maintenance dose was followed by three administrations of buprenorphine, 2 mg, at two hourly intervals (cumulative dose design).Main Outcome Measures: Subjects were assessed on digit symbol substitution test, trail making, digit span, and delayed recall, after each administration and the next morning. Results: Performance of subjects on Digit Symbol Substitution Test (χ2 = 52.98, p < 0.000) and Trail Making Test-A (χ2 = 26.29, p < 0.000) and B (χ2 = 42.08, p < 0.000) improved significantly with each assessment while other tests were unaffected.Conclusions: Improvement in psychomotor performance (which could be true effect of drug itself or a result of other factors, eg, inadequate maintenance dose or practice effect) though contrasting with some of the earlier findings, does have significant clinical implications regarding the long-term use of buprenorphine. It would be worthwhile repeating this type of study in a placebo controlled design to further verify the results.


Sign in / Sign up

Export Citation Format

Share Document